3AW Breakfast with Ross and Russel
Australian Personalised mRNA Cancer Immunotherapy Hub Head associate professor Seth Cheetham joined Ross Stevenson and Russel Howcroft to discuss an experimental melanoma drug that delivers treatment tailored to a patient's specific tumour which has prevented the deadly form of skin cancer from returning in a large clinical trial by US pharmaceutical giants Merck and Moderna. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.
10514 episodes
Comments
0Be the first to comment
Sign up now and become a member of the 3AW Breakfast with Ross and Russel community!